Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
September 30, 2026 -0.023M
June 30, 2026 4.466M
March 31, 2026 5.561M
December 31, 2025 20.38M
September 30, 2025 1.834M
June 30, 2025 -0.307M
March 31, 2025 5.044M
December 31, 2024 21.73M
September 30, 2024 -0.003M
June 30, 2024 0.105M
March 31, 2024 14.02M
December 31, 2023 -0.013M
September 30, 2023 0.807M
June 30, 2023 5.628M
March 31, 2023 0.001M
December 31, 2022 0.122M
September 30, 2022 0.964M
June 30, 2022 0.033M
March 31, 2022 0.513M
December 31, 2021 0.954M
September 30, 2021 3.719M
June 30, 2021 11.29M
March 31, 2021 20.96M
December 31, 2020 4.814M
September 30, 2020 24.56M
Date Value
June 30, 2020 0.503M
March 31, 2020 -0.01M
December 31, 2019 -0.005M
September 30, 2019 0.079M
June 30, 2019 -0.063M
March 31, 2019 0.606M
December 31, 2018 0.094M
September 30, 2018 0.145M
June 30, 2018 4.902M
March 31, 2018 0.633M
December 31, 2017 26.38M
September 30, 2017 4.992M
June 30, 2017 4.923M
March 31, 2017 19.10M
December 31, 2016 0.843M
September 30, 2016 12.21M
June 30, 2016 18.97M
March 31, 2016 0.764M
December 31, 2015 4.172M
September 30, 2015 11.16M
June 30, 2015 18.39M
March 31, 2015 5.684M
December 31, 2014 30.97M
September 30, 2014 0.4583M
June 30, 2014 20.06M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Curis, Inc. 5.69M
Armata Pharmaceuticals, Inc. -0.028M
Voyager Therapeutics, Inc. 3.033M
Black Diamond Therapeutics, Inc. 0.012M
Invivyd, Inc. 0.028M